Olema Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.08

-0.88 (-5.88%)

As of Mar 22, 10:04 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +19.4% upside

Low Target $15.48

Average Target $16.81

High Target $21.94

Current Price $14.08

Current
$14.08

Target
$16.81

$15.48 $16.81 avg $21.94

Scenario Analysis

Bear Case

$15.48

9.9%

Low target

Base Case

$16.81

+19.4%

Avg target

Bull Case

$21.94

+55.8%

High target

Risk/Reward

5.6x

Highly favorable

Price in Context

52-Week High

$36.26

-61.2% from high

52-Week Low

$2.86

+392.3% from low

Target vs 52W High

$16.81

-53.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%